25.40
Zenas Biopharma Inc (ZBIO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
1.00
|
- | - | - | - |
| Operating Expenses |
40.48%
108.66
|
77.35 | 237.98 | 52.58 | 55.16 |
| Operating Income/Loss |
39.18%
-107.66
|
-77.35 | -237.98 | -52.58 | -55.16 |
| Nonoperating Income/Loss |
1.26%
-3.683
|
-3.637 | -2.352 | 1.081 | 2.96 |
| Income/Loss From Continuing Operations Before Tax |
37.48%
-111.34
|
-80.99 | -240.34 | -51.50 | -52.20 |
| Income Tax Expense/Benefit |
0.114
|
- | 0.106 | - | 0.02 |
| Net Income/Loss |
37.62%
-111.46
|
-80.99 | -240.44 | -51.50 | -52.22 |
| Basic Average Shares |
13.46%
63.11
|
55.62 | - | 42.16 | 41.87 |
| Diluted Average Shares |
13.46%
63.11
|
55.62 | - | 42.16 | 41.87 |
| Basic Earnings Per Share |
21.23%
-1.77
|
-1.46 | - | -1.22 | -1.25 |
| Diluted Earnings Per Share |
21.23%
-1.77
|
-1.46 | - | -1.22 | -1.25 |
자본화:
|
볼륨(24시간):